About Omar Khalil
Omar Khalil is a director at Kestrel Therapeutics.
Omar Khalil first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Omar Khalil in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Omar Khalil works with at each company, as listed on that company's latest Form D.
Kestrel Therapeutics Inc. · Form D, Aug 12, 2025
NS
Nicholas Saccomano
Director
DP
Denis Patrick
Director
BS
Barbara Sosnowski
Director
AP
Andrew Phillips
Director
FH
Frank Haluska
President and Chief Executive Officer, director